SCHEMBL7228168

SCHEMBL7228168

Cc1noc(C)c1S(=O)(=O)N1CC[C@H]1C(=O)O

nearest known ligand 0.87

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 4/20 0.50
HPGD P15428 1/20 0.50
LMNA P02545 3/20 0.48
TSHR P16473 2/20 0.48
POLB P06746 3/20 0.47
ALDH1A1 P00352 1/20 0.46
HTT P42858 1/20 0.46
KMT2A Q03164 2/20 0.45
MAPK1 P28482 1/20 0.45
MEN1 O00255 1/20 0.45
TDP1 Q9NUW8 1/20 0.45
MAPT P10636 2/20 0.45
GLA P06280 1/20 0.45
HSD17B10 Q99714 1/20 0.45
MMP1 P03956 1/20 0.44
MMP3 P08254 1/20 0.44
MMP7 P09237 1/20 0.44
MMP9 P14780 1/20 0.44
MMP13 P45452 1/20 0.44
PKM P14618 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7011877 0.75 SMN1; SMN2 (0.42) SMN1; SMN2HPGDLMNATSHRPOLB
SCHEMBL20400928 0.71 STAT3 (0.41) LMNAPOLBALDH1A1HTTMMP13
SCHEMBL13037005 0.70 PSEN1 (0.49) SMN1; SMN2HPGDLMNATSHRPOLB
SCHEMBL20507216 0.69 CHRM4 (0.66) SMN1; SMN2HPGDLMNATSHRPOLB
SCHEMBL6214472 0.69 TSHR (0.66) SMN1; SMN2HPGDLMNATSHRPOLB
SCHEMBL5702094 0.68 ALDH1A1 (0.62) HPGDLMNATSHRPOLBALDH1A1
SCHEMBL5702221 0.68 ALDH1A1 (0.62) HPGDLMNATSHRPOLBALDH1A1
SCHEMBL4669530 0.68 ALDH1A1 (0.62) HPGDLMNATSHRPOLBALDH1A1
SCHEMBL4182416 0.67 MAPK1 (0.62) SMN1; SMN2HPGDLMNATSHRPOLB
SCHEMBL17327489 0.66 ALDH1A1 (0.41) LMNAPOLBALDH1A1HTTHSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6645939-B1 Very late antigen-4 (VLA) integrin antagonists; antiallergens, antiasthmatics, and antiinflammatory agents; multiple sclerosis, autoimmune disease treatment MERCK & CO., INC. 2003-11-11 US disclosed